Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page metadata; there are no changes to study content, results, or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:08:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site-wide funding notice was removed, and the trial record content (title, conditions, intervention, eligibility, and study dates) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T15:03:42.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The screenshots show no core content changes to the study details (eligibility, outcomes, or contact information); any differences appear to be minor layout or visual styling changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:33:57.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    - Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).
    Difference
    4%
    Check dated 2025-10-05T13:24:01.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.
    Difference
    0.6%
    Check dated 2025-09-28T09:36:25.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Updated version from v3.0.1 to v3.0.2; the 'Back to Top' link/button was removed. Overall, there are no changes to core content such as pricing, stock status, or time-slot information.
    Difference
    0.2%
    Check dated 2025-09-14T00:07:54.000Z thumbnail image

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.